IDEXX Laboratories, Inc.
IDXX Healthcare Diagnostics & Research
IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +9.86%
- EPS
- +17.3%
- Free cash flow
- +17.6%
- Total debt
- −28.6%
Quarter to September 2026, against a year earlier
Follow IDXX
Alert me
IDEXX Laboratories, Inc. (IDXX) Current ratio
IDEXX Laboratories, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 1.2×, down 0.0× from fiscal 2025 (1.2×). Over the past ten years it has ranged from 0.8× (fiscal 2018) to 1.8× (fiscal 2020); the current reading is higher than 64% of that period. That is below the Diagnostics & Research industry median of 2.3× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.2× | (6.12%) |
| FY2024 | 1.3× | (16.58%) |
| FY2023 | 1.6× | 76.30% |
| FY2022 | 0.9× | (28.78%) |
| FY2021 | 1.3× | (31.37%) |
| FY2020 | 1.8× | 94.62% |
| FY2019 | 0.9× | 10.35% |
| FY2018 | 0.8× | (12.25%) |
| FY2017 | 1.0× | 6.94% |
| FY2016 | 0.9× | (5.65%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 1.2× | 1.21% |
| Jun 2026 | 1.2× | 4.80% |
| Mar 2026 | 1.1× | (9.11%) |
| Dec 2025 | 1.2× | 4.31% |
| 43 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| NTRA Natera, Inc. compare | 2.8× |
| ILMN Illumina, Inc. compare | 2.6× |
| A Agilent Technologies, Inc. compare | 2.1× |
| DGX Quest Diagnostics Incorporated compare | 1.7× |
| LH Labcorp Holdings Inc. compare | 1.4× |
| IDXX IDEXX Laboratories, Inc. | 1.2× |
| MTD Mettler-Toledo International, Inc. compare | 1.1× |
| IQV IQVIA Holdings Inc. compare | 0.8× |
| WAT Waters Corporation compare | 0.7× |
| Diagnostics & Research industry median | 2.3× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on IDXX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement